Lorazepam
Product Images NDC 21695-239

2 FDA label images from Rebel Distributors Corp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 21695-239). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (90d64ec4 E3af 4e78 Bf7e 9d37699c98d2 01)

Chemical Structure (90d64ec4 E3af 4e78 Bf7e 9d37699c98d2 01)
Chemical structure diagram of Lorazepam showing its molecular framework, including chlorine-substituted benzene rings and characteristic ring structures.*
FDA Label Image

Lorazepam 0.5mg (90d64ec4 E3af 4e78 Bf7e 9d37699c98d2 02)

Lorazepam 0.5mg (90d64ec4 E3af 4e78 Bf7e 9d37699c98d2 02)
Lorazepam 0.5 mg tablets label by Rebel Distributors Corp, packaged by Physician Partner. The label indicates #90 tablets, USP Lorazepam 0.5 mg per tablet, round white unscored tablets with debossed markings. The label includes NDC number 21695-238-90 and identifies manufacturing by Sandoz Inc., Princeton, NJ. Storage instructions and packaging location are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.